Daan Gene Co Ltd

Daan Gene Co Ltd has a current ratio of 2.82, indicating a strong short-term liquidity position, but its free cash flow is negative at -730,083,730 CNY, suggesting ongoing capital outflows. The company's liquidity risk is assessed as medium, with a key flag indicating that net cash is negative after subtracting total debt. The debt-to-equity ratio is low at 0.03, reflecting a conservative capital structure. The company's profitability is weak, with a return on equity of -10.43% and a return on assets of -8.75%, both significantly below the industry median for medical equipment and biotechnology firms. Operating income is negative at -758,705,000 CNY, and net income is also negative at -744,378,900 CNY, indicating a substantial loss for the period. Daan Gene Co Ltd's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. The company's exposure to a single revenue stream increases its vulnerability to market fluctuations. No specific geographic breakdown is available in the input data, but the lack of diversification is a notable risk factor. The company's growth trajectory is uncertain, with no specific revenue growth or decline percentages provided in the input data. However, the negative operating and net income figures suggest a challenging operating environment. The capital expenditure of -238,999,280 CNY indicates ongoing investment in infrastructure, but the negative free cash flow suggests that these investments are not yet generating positive returns. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. However, the negative net cash position after debt is a concern for liquidity. No recent events such as filings or transcripts are provided in the input data to further assess risk exposure. The ESG profile of Daan Gene Co Ltd is mixed, with a low governance score of 12.82 and a high ESG controversies score of 100.00, indicating significant controversies in ESG practices. The social pillar score of 21.19 is also low, suggesting limited positive social impact. These ESG metrics may affect the company's reputation and long-term sustainability.